# Effect of DIRECT Transfer to ANGIOsuite on Functional Outcome in Severe Acute Stroke

> **NCT03969511** · NA · TERMINATED · sponsor: **Central Hospital, Nancy, France** · enrollment: 120 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **PROCEDURE:** direct angio-suite admission
- **PROCEDURE:** standard management

## Key facts

- **NCT ID:** NCT03969511
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-07-09
- **Primary completion:** 2023-07-25
- **Final completion:** 2024-04-03
- **Target enrollment:** 120 (ACTUAL)
- **Why stopped:** Following the interim analysis, the planned number of staff (208) will not be sufficient to achieve the main objective
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03969511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03969511, "Effect of DIRECT Transfer to ANGIOsuite on Functional Outcome in Severe Acute Stroke". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03969511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*